MedTrace Logo

Irritable Bowel Syndrome and Food Sensitivity

NCT02186743 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2017-10-18

No results posted yet for this study

Summary

The primary objective of the clinical trial portion of this study is to assess whether an individualized dietary plan based on a commercial food sensitivity assay provides specific benefit in a randomized controlled trial in adults with irritable bowel syndrome (IBS).

Conditions

  • Irritable Bowel Syndrome

Interventions

OTHER

Personalized Dietary Advice

Personalized dietary advice based on a commercially available blood test. Participants will be instructed to avoid eating selected foods for the duration of the intervention period (4 weeks). Some foods will be acceptable to consume every four days in rotation diet fashion.

Sponsors & Collaborators

  • Cell Science Systems, Corp.

    collaborator UNKNOWN

  • Yale University

    lead OTHER

Principal Investigators

  • Ather Ali, ND, MPH, MHS · Yale University

  • Wajahat Mehal, MD, PhD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02186743 on ClinicalTrials.gov